Insider · CIK 0001302390

Wolff Henry Ward

CIK 0001302390 Name as filed on the most recent filing

Filed as Wolff Henry Ward (31)

47 transaction lines · from 31 filings · filed 2010-08-30 to 2017-12-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

47 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2017-12-15 S, Open-market sale Portola Pharmaceuticals IncPTLA 2 lines 563,950, disposed Open Form 4 filing 0001209191-17-066238
2015-07-13 S, Open-market sale Sangamo Biosciences IncSGMO 2 lines 58,980, disposed Open Form 4 filing 0001140361-15-027517
2015-07-10 S, Open-market sale Sangamo Biosciences IncSGMO 61,020, disposed Open Form 4 filing 0001140361-15-027517
2015-06-10 S, Open-market sale Sangamo Biosciences IncSGMO 2 lines 146,558, disposed Open Form 4 filing 0001140361-15-024139
2015-05-11 S, Open-market sale Sangamo Biosciences IncSGMO 2 lines 158,949, disposed Open Form 4 filing 0001140361-15-019411
2015-04-10 S, Open-market sale Sangamo Biosciences IncSGMO 3 lines 183,771, disposed Open Form 4 filing 0001140361-15-015373
2015-03-19 S, Open-market sale Sangamo Biosciences IncSGMO 180,000, disposed Open Form 4 filing 0001140361-15-012876
2015-03-10 S, Open-market sale Sangamo Biosciences IncSGMO 2 lines 200,201, disposed Open Form 4 filing 0001140361-15-011606
2015-03-04 S, Open-market sale Sangamo Biosciences IncSGMO 180,000, disposed Open Form 4 filing 0001140361-15-010832
2015-02-10 S, Open-market sale Sangamo Biosciences IncSGMO 3 lines 151,750, disposed Open Form 4 filing 0001140361-15-006119
2015-01-12 S, Open-market sale Sangamo Biosciences IncSGMO 2 lines 190,450, disposed Open Form 4 filing 0001140361-15-001831
2014-11-10 S, Open-market sale Sangamo Biosciences IncSGMO 22,748, disposed Open Form 4 filing 0001209191-14-068660
2014-10-10 S, Open-market sale Sangamo Biosciences IncSGMO 20,200, disposed Open Form 4 filing 0001209191-14-063173
2014-09-10 S, Open-market sale Sangamo Biosciences IncSGMO 24,620, disposed Open Form 4 filing 0001209191-14-057787
2014-08-11 S, Open-market sale Sangamo Biosciences IncSGMO 2 lines 141,677, disposed Open Form 4 filing 0001209191-14-052015
2014-07-10 S, Open-market sale Sangamo Biosciences IncSGMO 2 lines 198,902, disposed Open Form 4 filing 0001209191-14-046840
2014-06-10 S, Open-market sale Sangamo Biosciences IncSGMO 2 lines 234,328, disposed Open Form 4 filing 0001209191-14-040714
2014-05-12 S, Open-market sale Sangamo Biosciences IncSGMO 2 lines 192,756, disposed Open Form 4 filing 0001209191-14-033889
2014-04-10 S, Open-market sale Sangamo Biosciences IncSGMO 2 lines 235,798, disposed Open Form 4 filing 0001209191-14-027224
2014-03-10 S, Open-market sale Sangamo Biosciences IncSGMO 223,071, disposed Open Form 4 filing 0001209191-14-020051
2014-02-10 S, Open-market sale Sangamo Biosciences IncSGMO 192,638, disposed Open Form 4 filing 0001209191-14-009947
2014-01-10 S, Open-market sale Sangamo Biosciences IncSGMO 186,893, disposed Open Form 4 filing 0001209191-14-003192
2013-12-10 S, Open-market sale Sangamo Biosciences IncSGMO 119,670, disposed Open Form 4 filing 0001181431-13-062622
2013-11-13 S, Open-market sale Sangamo Biosciences IncSGMO 100,000, disposed Open Form 4 filing 0001181431-13-059326
2013-10-10 S, Open-market sale Sangamo Biosciences IncSGMO 112,763, disposed Open Form 4 filing 0001181431-13-053920
2013-09-10 S, Open-market sale Sangamo Biosciences IncSGMO 108,593, disposed Open Form 4 filing 0001181431-13-048828
2013-08-13 S, Open-market sale Sangamo Biosciences IncSGMO 100,000, disposed Open Form 4 filing 0001181431-13-045141
2013-07-17 S, Open-market sale Sangamo Biosciences IncSGMO 100,000, disposed Open Form 4 filing 0001181431-13-040864
2013-04-10 S, Open-market sale Sangamo Biosciences IncSGMO 100,000, disposed Open Form 4 filing 0001181431-13-022106
2013-02-28 S, Open-market sale Sangamo Biosciences IncSGMO 100,000, disposed Open Form 4 filing 0001181431-13-013714
2013-01-23 S, Open-market sale Sangamo Biosciences IncSGMO 100,000, disposed Open Form 4 filing 0001181431-13-004948
2010-08-30 P, Open-market purchase Sangamo Biosciences IncSGMO 27,000, acquired Open Form 4 filing 0001181431-10-044815

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 46
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Wolff Henry Ward, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001302390

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.